Volume 9, Issue 1 ( March 2017 2017)                   Iranian Journal of Blood and Cancer 2017, 9(1): 24-26 | Back to browse issues page

XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Narayanan G, Anoop T M, Haridas L, V Soman L. Hodgkin’s Lymphoma Occurring Secondary to Autologous Stem Cell Transplantation in Plasma Cell Leukemia; A Case Report. Iranian Journal of Blood and Cancer 2017; 9 (1) :24-26
URL: http://ijbc.ir/article-1-707-en.html
1- Department of Medical Oncology, Regional Cancer Centre, Trivandrum 695011, Kerala, India , geenarayanan@yahoo.com
2- Department of Medical Oncology, Regional Cancer Centre, Trivandrum 695011, Kerala, India
Abstract:   (5003 Views)

Survival of patients with multiple myeloma has improved substantially because of availability of new therapies including autotransplants, immunomodulating drugs and proteasome-inhibitors. Second primary cancers have emerged as an important determinant of morbidity and mortality among cancer survivors. Even though there is an increased risk of new cancers of the lymphoreticular and haematopoetic system, it is very rare for Hodgkin’s lymphoma to occur as a second malignancy following autologous peripheral blood stem cell transplantation (APBSCT) for myeloma. We report a case of a female with plasma cell leukemia treated with autologous peripheral blood stem cell transplantation and lenalidamide maintenance. She developed cervical lymphadenopathy 4.5 years after the APBSCT, biopsy confirmed the diagnosis of classical Hodgkin’s lymphoma, nodular sclerosis type. Since she developed allergic reaction to ABVD, she was given 6 cycles of COPP chemotherapy and is in complete remission now.

Full-Text [PDF 524 kb]   (1802 Downloads)    
: Case report | Subject: Adults Hematology & Oncology
Received: 2017/01/21 | Accepted: 2017/02/8 | Published: 2017/04/3

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 All Rights Reserved | Iranian Journal of Blood and Cancer

Designed & Developed by : Yektaweb